ziprasidone

Also known as CP-88059, CP-88059-27, CP-880591, CP-8805927, Geodon®, Ziprasidone hydrochloride, Geodon

Ziprasidone, sold under the brand name Geodon among others, is an atypical antipsychotic used to treat schizophrenia and bipolar disorder. It may be used by mouth and by injection into a muscle (IM). The intramuscular form may be used for acute agitation in people with schizophrenia.

Key facts

Drug.Watchedfields: changed
Drug.verifiedrevid: 470637441
Drug.image: Ziprasidone.svg
Drug.image_class: skin-invert-image
Drug.width: 250px
Drug.image2: Ziprasodone-3D-Ball-And-Stick-Model.png
Drug.image_class2: bg-transparent
Drug.width2: 250px
Drug.tradename: Geodon, others
Drug.MedlinePlus: a699062
Drug.DailyMedID: Ziprasidone
Drug.pregnancy_AU: C
Drug.routes_of_administration

Article

15 sections

Contents

Medical uses
Adverse effects
Discontinuation
Pharmacology
Pharmacodynamics
Correspondence to clinical effects
Pharmacokinetics
History
Society and culture
Lawsuit
Brand names
Research
See also
References
Further reading

{{Infobox drug | Watchedfields = changed | verifiedrevid = 470637441 | image = Ziprasidone.svg | image_class = skin-invert-image | width = 250px | alt = | image2 = Ziprasodone-3D-Ball-And-Stick-Model.png | image_class2 = bg-transparent | width2 = 250px | alt2 = | pronounce = | tradename = Geodon, others | Drugs.com = | MedlinePlus = a699062 | DailyMedID = Ziprasidone | pregnancy_AU = C | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth, intramuscular injection (IM) | class = Atypical antipsychotic | ATC_prefix = N05 | ATC_suffix = AE04 | ATC_supplemental = | legal_AU = S4 | legal_AU_comment = | legal_BR = C1 | legal_BR_comment = | legal_CA = | legal_CA_comment = | legal_DE = | legal_DE_comment = | legal_NZ = | legal_NZ_comment = | legal_UK = | legal_UK_comment = | legal_US = Rx-only | legal_US_comment = | legal_EU = | legal_EU_comment = | legal_UN = | legal_UN_comment = | legal_status =